Immunotech Biopharm shares halted pending rights issue announcement

Trading in the shares of Immunotech Biopharm Ltd was halted on the Hong Kong Stock Exchange at 9:00 a.m. on Friday, 19 September 2025. The suspension is pending the release of an announcement concerning a rights issue, which constitutes inside information for the company.

The board of directors includes Mr. Tan Zheng as chairman and executive director, Ms. Yu Xiaohui, Mr. Yang Fan, Mr. Wang Ruihua, Mr. Wang Donghu, Mr. Yang Xin, and Mr. Liu Rui as non-executive directors. Independent non-executive directors are Professor Wang Yingdian, Mr. Ng Chi Kit, Ms. Peng Sujiu, and Mr. Zhang Guoguang.